Somatostatin octapeptides

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSomatostatin octapeptides
Drug Alias NameN/A
ClassificationDiagnostic agent (In vivo)Small molecules > Synthetic peptide
Mechanisms of ActionSomatostatin receptor agonists
TargetsSomatostatin receptor
Therapy Area/IndicationsBreast NeoplasmsNeuroendocrine Tumors
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesThe Ohio State University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNavidea BiopharmaceuticalsThe Ohio State University
Active IndicationsN/A
Inactive IndicationsBreast NeoplasmsNeuroendocrine Tumors

Other Information

ATC CodeN/A
Related LinksN/A